Bioanalysis 2012-07-01

Determination of dimethyltryptamine and β-carbolines (ayahuasca alkaloids) in plasma samples by LC-MS/MS.

Carolina Dizioli Rodrigues Oliveira, Guilherme Gonçalves Okai, José Luiz da Costa, Rafael Menck de Almeida, Diogo Oliveira-Silva, Mauricio Yonamine

Index: Bioanalysis 4(14) , 1731-8, (2012)

Full Text: HTML

Abstract

Ayahuasca is a psychoactive plant beverage originally used by indigenous people throughout the Amazon Basin, long before its modern use by syncretic religious groups established in Brazil, the USA and European countries. The objective of this study was to develop a method for quantification of dimethyltryptamine and β-carbolines in human plasma samples.The analytes were extracted by means of C18 cartridges and injected into LC-MS/MS, operated in positive ion mode and multiple reaction monitoring. The LOQs obtained for all analytes were below 0.5 ng/ml. By using the weighted least squares linear regression, the accuracy of the analytical method was improved at the lower end of the calibration curve (from 0.5 to 100 ng/ml; r(2)> 0.98).The method proved to be simple, rapid and useful to estimate administered doses for further pharmacological and toxicological investigations of ayahuasca exposure.

Related Compounds

  • Dimethyltryptamine

Related Articles:

Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class.

2016-01-22

[Toxicol. Lett. 241 , 82-94, (2015)]

Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases.

2014-04-01

[Biochem. Pharmacol. 88(3) , 393-401, (2014)]

Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.

2012-01-01

[Drug Test. Anal. 4(7-8) , 610-6, (2012)]

Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.

2011-09-01

[Biomed. Chromatogr. 25(9) , 970-84, (2011)]

Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.

2009-12-01

[J. Neural Transm. Gen. Sect. 116(12) , 1591-9, (2009)]

More Articles...